-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Maintains Buy on RAPT Therapeutics, Raises Price Target to $41

Benzinga·09/30/2025 12:27:23
Listen to the news
Clear Street analyst Kaveri Pohlman maintains RAPT Therapeutics (NASDAQ:RAPT) with a Buy and raises the price target from $24 to $41.